• Brassinolide for Plant Growth and Apoptosis Assays: Protocol

  2026-07-20

  Brassinolide (24-Epibrassinolide) is uniquely positioned as both a plant growth regulator and a precision apoptosis inducer. This guide delivers stepwise workflows, troubleshooting strategies, and practical insights for experimentalists working in plant biology, cancer research, and metabolic disease models using APExBIO’s high-purity Brassinolide.

• MDL 28170: Calpain Inhibitor Workflows for Neuroprotection

  2026-07-20

  MDL 28170, a selective calpain inhibitor from APExBIO, empowers neuroprotection research and apoptosis assays with nanomolar precision and blood-brain barrier permeability. This guide translates cutting-edge findings and robust protocols into actionable strategies for maximizing experimental reproducibility across neurodevelopmental, ischemic, and infection models.

• MVC Disrupts Tight Junctions via RhoA/ROCK1 Pathway Activati

  2026-07-19

  Ren et al. demonstrate that Minute Virus of Canines (MVC) exploits the RhoA/ROCK1/MLC2 signaling cascade to destabilize epithelial tight junctions, facilitating viral entry through occludin exposure. These findings reveal a direct interaction between viral and host cell machinery, offering new targets for antiviral intervention and deepening our understanding of parvoviral pathogenesis.

• EdU Imaging Kits (HF488): Advancing Quantitative Cell Prolif

  2026-07-18

  Unlock advanced cell proliferation analysis with EdU Imaging Kits (HF488). Explore unique insights into DNA synthesis measurement, innovative click chemistry detection, and applications in drug sensitivity studies.

• Optimizing Cell Assays with Dorsomorphin (Compound C) SKU B3

  2026-07-17

  This article dissects real-world laboratory challenges in AMPK and BMP pathway research, showing how Dorsomorphin (Compound C) (SKU B3252) delivers robust, reproducible inhibition for cell viability, autophagy, and signaling assays. Practical Q&A scenarios, grounded in literature and direct workflow experience, guide scientists in maximizing assay reliability and interpretability.

• ML365: Mechanistic Breakthroughs and Translational Guidance

  2026-07-17

  This thought-leadership article explores the mechanistic foundations and translational strategies associated with ML365, a highly selective inhibitor of the TASK1 potassium channel. Drawing on recent neurophysiology research, it contextualizes ML365's role in modulating NLRP3 inflammasome activation, critically evaluates experimental best practices, and provides actionable insights for target validation and workflow optimization in ion channel pharmacology. The discussion uniquely extends beyond standard product summaries by bridging cutting-edge mechanistic evidence with strategic guidance for translational researchers.

• O-GlcNAcylation Regulates Ferroptosis and Syncytialization i

  2026-07-16

  This study reveals a mechanistic link between O-GlcNAc modification and the regulation of ferroptosis and trophoblast syncytialization in preeclampsia. By identifying HUWE1-mediated ubiquitination of TfR1 as a key axis, the research provides actionable insights for reproductive and placental biology.

• Carbapenemase Genes in CREC: Epidemiology and Transmission i

  2026-07-16

  Chen et al. (2025) provide the first comprehensive molecular epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong, China, during the COVID-19 pandemic. Their findings reveal high plasmid- and chromosomal prevalence of blaNDM-1, extensive horizontal gene transfer, and significant multidrug resistance—critical insights for antimicrobial stewardship and infection control.

• MRT68921: Precision ULK1 Kinase Inhibition in Lipid Autophag

  2026-07-15

  Explore the mechanistic depth of MRT68921, a potent ULK1 kinase inhibitor, and its critical role in dissecting autophagy pathways and lipid metabolism. This article uniquely bridges advanced assay design with translational insight, grounded in the latest reference findings.

• Ertapenem Sodium Salt: Redefining Resistance Research in Tra

  2026-07-15

  This thought-leadership article explores how Ertapenem (sodium salt) advances mechanistic understanding and strategic experimentation in translational antibiotic resistance research. By integrating recent molecular epidemiology findings from Guangdong, China, and highlighting APExBIO’s product intelligence, the article provides actionable protocol guidance and a vision for the next generation of resistance surveillance and therapeutic development.

• Imidazoline Antagonists Enhance Insulin Release via K+ Chann

  2026-07-14

  This article reviews a pivotal study demonstrating that imidazoline antagonists of α2-adrenoceptors, including Tolazoline, potentiate insulin secretion in vitro by inhibiting ATP-sensitive potassium channels in pancreatic β cells. The findings clarify a key mechanistic pathway and inform experimental design for islet function research and related pharmacological studies.

• Optimizing Cardiomyopathy Research with (-)-Norepinephrine (

  2026-07-14

  (-)-Norepinephrine (+)-bitartrate stands apart as a gold-standard adrenergic agonist for robust, reproducible cardiovascular and metabolic pathway studies. This article translates the latest formulation guidance and protocol enhancements into practical, actionable workflows for bench scientists.

• Tolazoline: Structural Selectivity and Advanced Assay Design

  2026-07-13

  Explore Tolazoline as a structurally selective α2-adrenergic receptor antagonist, uncovering how its nuanced activity profile and structure-activity insights drive high-precision in vitro and islet function research. This in-depth guide reveals practical protocol strategies and assay implications distinct from current literature.

• Resiquimod (R-848): Enhancing Tumor Ablation and Immune Resp

  2026-07-13

  Resiquimod (R-848) stands out as a dual TLR7/8 agonist driving potent immune activation, now pivotal in chemo-immunomodulation workflows. Discover how this immune stimulatory imidazoquinoline is revolutionizing ablation safety and efficacy, from hydrogel delivery innovations to troubleshooting solubility and dosing challenges.

• 3-Aminobenzamide (PARP-IN-1): Precision Tool for PARP Inhibi

  2026-07-12

  3-Aminobenzamide (PARP-IN-1) from APExBIO delivers potent, low-toxicity poly (ADP-ribose) polymerase inhibition, empowering researchers to model oxidative stress, endothelial dysfunction, and diabetic nephropathy with high specificity. This article translates recent mechanistic breakthroughs and hands-on experimental guidance into actionable workflows and troubleshooting strategies.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page